IP Library Granted Patent US 9,309,563
Granted Patent B2
US 9,309,563 · App. 10/900,453 · Granted Apr 12, 2016

Compositions and processes for analyte detection, quantification and amplification

Inventors: Elazar Rabbani (New York, NY); Jannis G. Stavrianopoulos (Bayshore, NY); James J. Donegan (Long Beach, NY); Jack Coleman (East Northport, NY)
Assignee: Enzo Life Sciences, Inc.
C12Q1/6837C07H21/00C12N15/1058C12Q1/6809C12Q1/6825C07B2200/11C40B40/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,309,563
App. No.
10/900,453
Granted
Apr 12, 2016
Kind
B2
Abstract

This invention provides novel compositions and processes for analyte detection, quantification and amplification. Nucleic acid arrays and libraries of analytes are usefully incorporated into such compositions and processes. Universal detection elements, signaling entities and the like are employed to detect and if necessary or desirable, to quantify analytes. Amplification of target analytes are also provided by the compositions and processes of this invention.

Claims (52)

1. A process for detecting or quantifying multiple different nucleic acid species of interest in a library, the process comprising the steps of:

a) providing:

(i) an array of fixed or immobilized nucleic acids complementary to said nucleic acid species of interest;

(ii) a library of nucleic acid analytes isolated or derived from a biological source, which library of nucleic acid analytes may contain the nucleic acid species of interest sought to be detected or quantified, wherein each of said nucleic acid species of interest comprises at least one inherent universal detection target (UDT); and

(iii) labeled universal detection elements (UDE) which generate a signal directly or indirectly;

b) hybridizing said library (ii) with said array of nucleic acids (i) to form hybrids if said nucleic acid species of interest are present, thereby binding said nucleic acid species of interest comprising said inherent UDTs to said array;

c) contacting said inherent UDTs on said nucleic acid species of interest bound to said array with said labeled UDEs to form a complex between said labeled UDEs and said inherent UDTs, wherein said complex is bound to said array, and wherein the sequence of said labeled UDE consists of a sequence that binds to a 3′ polyA segment, or a consensus sequence when said inherent UDT is a nucleic acid; and

d) detecting or quantifying said multiple different nucleic acid species of interest by detecting or measuring the amount of signal generated from labeled UDEs complexed to inherent UDTs on each nucleic acid species of interest bound to said array.

2. The process of claim 1 , wherein said nucleic acid array comprises DNA, RNA, DNA analogs, RNA analogs, or a combination of the foregoing.

3. The process of claim 2 , wherein said nucleic acid array comprises PNA.

4. The process of claim 1 , wherein said solid support is porous.

5. The process of claim 4 , wherein said porous solid support comprises polyacrylamide or agarose.

6. The process of claim 1 , wherein said solid support is non-porous.

7. The process of claim 6 , wherein said non-porous solid support comprises glass or plastic.

8. The process of claim 1 , wherein said solid support is transparent, translucent, opaque or reflective.

9. The process of claim 1 , wherein said nucleic acids are directly fixed or immobilized to said solid support.

10. The process of claim 1 , wherein said nucleic acids are indirectly fixed or immobilized to said solid support by means of a chemical linker or linkage arm.

11. The process of claim 1 , wherein said biological source comprises organs, tissues or cells.

12. The process of claim 1 , wherein said analytes comprise genomic DNA, episomal DNA, unspliced RNA, mRNA, rRNA, snRNA, or a combination of any of the foregoing.

13. The process of claim 1 , wherein said inherent UDT comprises a 3′ polyA segment, a 5′ cap, a secondary structure, or a consensus sequence, or a combination of any of the foregoing.

14. The process of claim 13 , wherein said inherent UDT is a consensus sequence that comprises a signal sequence for polyA addition, a splicing element, a multicopy repeat, or a combination of any of the foregoing.

15. The process of claim 1 , Wherein said UDE comprises a nucleic acid, a nucleic acid analog, a polypeptide, a polysaccharide, a synthetic polymer, or a combination of any of the foregoing.

16. The process of claim 1 , wherein said signal generated from said labeled UDE is a direct signal from an agent comprising a fluorescent compound, a phosphorescent compound, a chemiluminescent compound, a chelating compound, an electron dense compound, a magnetic compound, an intercalating compound, an energy transfer compound, or a combination of any of the foregoing.

17. The process of claim 1 , wherein said signal generated from said labeled UDE is an indirect signal from an agent comprising an antibody, an antigen, a hapten, a receptor, a hormone, a ligand, an enzyme, or a combination of any of the foregoing.

18. The process of claim 17 , wherein said indirect signal is from an agent comprising an enzyme that catalyzes a reaction comprising a fluorogenic reaction, a chromogenic reaction or a chemiluminescent reaction.

19. The process of claim 1 , comprising one or more washing steps.

20. A process for detecting or quantifying multiple different nucleic acid species of interest in a library, the process comprising the steps of:

a) providing:

(i) an array of fixed or immobilized nucleic acids complementary to said nucleic acid species of interest;

(ii) a library of nucleic acid analytes isolated or derived from a biological source, which library of nucleic acid analytes may contain the nucleic acid species of interest sought to be detected or quantified, wherein each of said nucleic acid species of interest comprises at least one inherent universal detection target (UDT); and

(iii) labeled universal detection elements (UDE) which generate a signal directly or indirectly;

b) contacting said inherent UDTs on said nucleic acid species of interest with said labeled UDEs in said library of nucleic acid analytes to form one or more complexes, wherein the sequence of said labeled UDE consists of a sequence that binds to a 3′ polyA segment, or a consensus sequence when said inherent UDT is a nucleic acid;

c) hybridizing said library of nucleic acid analytes with said array of nucleic acids (i) to form hybrids if said nucleic acid species of interest are present, wherein said one or more formed complexes are bound to said array; and

d) detecting or quantifying said multiple different nucleic acid species of interest by detecting or measuring the amount of signal generated from labeled UDEs complexed to inherent UDTs on each nucleic acid species of interest bound to said array.

21. The process of claim 20 , wherein said nucleic acid array comprises DNA, RNA, DNA analogs, RNA analogs, or a combination of the foregoing.

22. The process of claim 21 , wherein said nucleic acid array comprises PNA.

23. The process of claim 20 , wherein said solid support is porous.

24. The process of claim 23 , wherein said porous solid support comprises polyacrylamide or agarose.

25. The process of claim 20 , wherein said solid support is or non-porous.

26. The process of claim 25 , Wherein said non-porous solid support comprises glass or plastic.

27. The process of claim 20 , wherein said solid support is transparent, translucent, opaque or reflective.

28. The process of claim 20 , wherein said nucleic acids are directly fixed or immobilized to said solid support.

29. The process of claim 20 , wherein said nucleic acids are indirectly fixed or immobilized to said solid support by means of a chemical linker or linkage arm.

30. The process of claim 20 , wherein said biological source comprises organs, tissues or cells.

31. The process of claim 20 , wherein said analytes comprise genomic DNA, episomal DNA, unspliced RNA, mRNA, rRNA, snRNA, or a combination of any of the foregoing.

32. The process of claim 20 , wherein said inherent UDT comprises a 3′ polyA segment, a 5′ cap, a secondary structure, a consensus sequence, or a combination of any of the foregoing.

33. The process of claim 32 , wherein said inherent UDT is a consensus sequence that comprises a signal sequence for polyA addition, a splicing element, a multicopy repeat, or a combination of any of the foregoing.

34. The process of claim 20 , wherein said UDE comprises a nucleic acid, a nucleic acid analog, a polypeptide, a polysaccharide, a synthetic polymer or a combination of any of the foregoing.

35. The process of claim 20 , wherein said signal generated from said labeled UDE is a direct signal from an agent comprising a fluorescent compound, a phosphorescent compound, a chemiluminescent compound, a chelating compound, an electron dense compound, a magnetic compound, an intercalating compound, an energy transfer compound, or a combination of any of the foregoing.

36. The process of claim 20 , wherein said signal generated from said labeled UDE is an indirect signal from an agent comprising an antibody, an antigen, a hapten, a receptor, a hormone, a ligand, an enzyme, or a combination of any of the foregoing.

37. The process of claim 36 , wherein said indirect signal is from an agent comprising an enzyme that catalyzes a reaction comprising a fluorogenic reaction, a chromogenic reaction or a chemiluminescent reaction.

38. The process of claim 20 , comprising one or more washing steps.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2026
From: ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES, INC.; ENZO THERAPEUTICS, INC.
To: SERAPH BIOTECH CONSULTING, LLC
Reel/Frame 075219/0465 →
RELEASE OF SECURITY INTEREST Recorded Jul 24, 2023
From: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
To: ENZO BIOCHEM, INC.; ENZO CLINICAL LABS, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP; ENZO LIFE SCIENCES, INC.
Reel/Frame 064369/0031 →
SECURITY INTEREST Recorded Apr 3, 2023
From: ENZO LIFE SCIENCES, INC.; ENZO CLINICAL LABS, INC.; ENZO BIOCHEM, INC.; ENZO LIFE SCIENCES U.S. HOLDING CORP
To: GEMINO HEALTHCARE FINANCE, LLC D/B/A SLR HEALTHCARE ABL
Reel/Frame 063239/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2015
From: RABBANI, ELAZAR; STAVRIANOPOULOS, JANNIS G.; DONEGAN, JAMES J.; COLEMAN, JACK
To: ENZO LIFE SCIENCES, INC.
Reel/Frame 036770/0928 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2015
From: RABBANI, ELAZAR; STAVRIANOPOULOS, JANNIS G.; DONEGAN, JAMES J.; COLEMAN, JACK
To: ENZO LIFE SCIENCES, INC.
Reel/Frame 036771/0115 →
Continuity (2)
Division 09896897 · Jun 30, 2001
Related Publication 20060099601A1 · May 11, 2006